Advances in laparoscopic surgery for cervical cancer.


Journal

Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049

Informations de publication

Date de publication:
11 2019
Historique:
received: 07 05 2018
revised: 02 08 2018
accepted: 29 07 2019
pubmed: 10 9 2019
medline: 21 1 2020
entrez: 10 9 2019
Statut: ppublish

Résumé

In the recent years, minimally invasive surgery has emerged as the gold standard for the treatment of both benign and malignant gynecological conditions. Growing evidence suggest that laparoscopic and robotic-assisted treatments allow to archived the same long-term outcomes than conventional open abdominal treatments, minimizing peri-operative morbidity. In the present review we analyzed the advances in the treatment of cervical cancer patients, reporting the advances in both the evolution of concept of radical hysterectomy and of the adoption of minimally invasive surgery. We discussed the advantages related to the introduction of minimally invasive treatment for cervical cancer patients; innovation of conventional laparoscopic surgery as discussed as well. Recent evidence suggested a potential detrimental effect on long-term survival outcomes related to the use of minimally invasive surgery in patients affected by cervical cancer. However, reasons why minimally invasive surgery might have a detrimental effect are still unclear. Further evidence is needed in order to improve quality of treatment for cervical cancer patients.

Identifiants

pubmed: 31499276
pii: S1040-8428(18)30211-7
doi: 10.1016/j.critrevonc.2019.07.021
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

76-80

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Giorgio Bogani (G)

Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy. Electronic address: giorgio.bogani@istitutotumori.mi.it.

Umberto Leone Roberti Maggiore (U)

Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.

Diego Rossetti (D)

Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.

Antonino Ditto (A)

Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.

Fabio Martinelli (F)

Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.

Valentina Chiappa (V)

Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.

Stefano Ferla (S)

Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.

Alice Indini (A)

Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.

Ilaria Sabatucci (I)

Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.

Domenica Lorusso (D)

Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.

Francesco Raspagliesi (F)

Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH